Tinker, AV; Gebski, V; Fitzharris, B; Buck, M; Stuart-Harris, Robin; Beale, Phillip; Goldrick, A; Rischin, D
Objective: To determine the response rate of weekly docetaxel in women with relapsed epithelial ovarian cancer previously treated with paclitaxel and at least one line of platinum-based chemotherapy. Methods: In this multi-center phase II trial, 37 patients with relapsed disease were enrolled and treated with weekly docetaxel at 35 mg/m for 5 out of 6 consecutive weeks. Two patient cohorts were considered, those who progressed or relapsed within 4 months (N = 7) or at greater than 4 months (N =...[Show more]
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.